Biocon-Mylan programmes make clinical progress
PEG-G-CSF and Adalimumab enter phase II while patient recruitment for one insulin Glargine phase II study is complete
Biocon has…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.